Clinical trials
Completed Stomach Neoplasms trials in South Korea
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
242 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 6 |
| 2004 | 5 |
| 2005 | 2 |
| 2006 | 11 |
| 2007 | 5 |
| 2008 | 8 |
| 2009 | 11 |
| 2010 | 18 |
| 2011 | 13 |
| 2012 | 20 |
| 2013 | 14 |
| 2014 | 15 |
| 2015 | 17 |
| 2016 | 15 |
| 2017 | 14 |
| 2018 | 10 |
| 2019 | 16 |
| 2020 | 13 |
| 2021 | 9 |
| 2022 | 7 |
| 2023 | 8 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 242 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Yonsei University | 38 |
| Samsung Medical Center | 16 |
| Asan Medical Center | 15 |
| National Cancer Center, Korea | 13 |
| Seoul National University Hospital | 12 |
| Seoul National University Bundang Hospital | 11 |
| Hoffmann-La Roche | 8 |
| Ajou University School of Medicine | 7 |
| Gangnam Severance Hospital | 7 |
| Eli Lilly and Company | 5 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Stomach Neoplasms | 242 |
| Breast Neoplasms | 11 |
| Neoplasm Metastasis | 11 |
| Colorectal Neoplasms | 10 |
| Neoplasms | 8 |
| Esophageal Neoplasms | 7 |
| Ovarian Neoplasms | 7 |
| Pancreatic Neoplasms | 7 |
| Carcinoma, Non-Small-Cell Lung | 6 |
| Adenocarcinoma | 5 |
Trials
Showing 1 to 25 of 242. Each trial links to its page on Pharma Observatory.
142 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.